In trading on Friday, shares of Medicines Co (MDCO) touched a new 52-week high of $45.31/share. That's a 64.76% rise, or $17.81 per share from the 52-week low of $27.50 set back on 02/11/2016. That means at today's intraday high, any investor who purchased MDCO stock any time over the past 52 weeks has an unrealized gain, including company insiders.

Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, MDCO has seen 2 different instances of insiders buying over the trailing six month period.

START SLIDESHOW:
Ten Bargains You Can Buy Cheaper Than The Insiders Did »

Purchased Insider Title Shares Price/Share Value
12/08/2016 Fredric N. Eshelman Director 621,720 $33.77 $20,993,462.41
12/08/2016 Christopher T. Cox EVP & Chief Corp. Dev. Officer 105,500 $33.20 $3,502,950.00

The chart below shows where MDCO has traded over the past year, with the 50-day and 200-day moving averages included.

Medicines Co  Moving Averages Chart

In afternoon trading on Friday, MDCO shares are changing hands at $44.90/share, slightly below the new 52-week high.

More from Stocks

It's Harvest Season for Tax Losses

It's Harvest Season for Tax Losses

Santa Claus Rally? Machines Render Old Stock Market Adages Worthless

Santa Claus Rally? Machines Render Old Stock Market Adages Worthless

Procter & Gamble Helps Lead Dow Jones After Upgrade From Morgan Stanley

Procter & Gamble Helps Lead Dow Jones After Upgrade From Morgan Stanley

Hey Investors, Don't Let the Bad Times Pollute Your Mind

Hey Investors, Don't Let the Bad Times Pollute Your Mind

Make This Dividend Aristocrat a Staple of Your Portfolio

Make This Dividend Aristocrat a Staple of Your Portfolio